Edmond de Rothschild Holding’s Elevance Health ELV Stock Holding History

Edmond de Rothschild Holding’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$423K	Sell	1,094 -4,926	-82%	-$1.83M	0.01%	385
2026 Q1	$1.76M	Sell	6,020 -2,841	-32%	-$934K	0.03%	246
2025 Q4	$3.11M	Buy	8,861 +4,192	+90%	+$1.42M	0.04%	204
2025 Q3	$1.51M	Sell	4,669 -1,616	-26%	-$503K	0.02%	267
2025 Q2	$2.44M	Sell	6,285 -24,345	-79%	-$9.79M	0.04%	216
2025 Q1	$13.3M	Buy	30,630 +322	+1%	+$129K	0.24%	101
2024 Q4	$11.2M	Buy	30,308 +508	+2%	+$213K	0.19%	116
2024 Q3	$15.5M	Buy	29,800 +2,445	+9%	+$1.31M	0.25%	99
2024 Q2	$14.8M	Sell	27,355 -7,484	-21%	-$3.96M	0.25%	95
2024 Q1	$18.1M	Sell	34,839 -9,019	-21%	-$4.49M	0.3%	88
2023 Q4	$20.7M	Buy	43,858 +788	+2%	+$364K	0.37%	75
2023 Q3	$18.8M	Buy	43,070 +3,848	+10%	+$1.75M	0.38%	71
2023 Q2	$17.4M	Buy	39,222 +1,599	+4%	+$738K	0.34%	79
2023 Q1	$17.3M	Buy	37,623 +8,783	+30%	+$4.18M	0.39%	69
2022 Q4	$14.8M	Hold	28,840	–	–	0.34%	84
2022 Q3	$13.1M	Hold	28,840	–	–	0.35%	87
2022 Q2	$13.9M	Sell	28,840 -16,220	-36%	-$8.02M	0.34%	85
2022 Q1	$22.1M	Sell	45,060 -7,018	-13%	-$3.21M	0.48%	62
2021 Q4	$24.1M	Sell	52,078 -7,216	-12%	-$3.04M	0.52%	54
2021 Q3	$22.1M	Buy	59,294 +5,370	+10%	+$2.04M	0.51%	57
2021 Q2	$20.6M	Buy	53,924 +3,118	+6%	+$1.19M	0.48%	65
2021 Q1	$18.2M	Buy	50,806 +5,336	+12%	+$1.72M	0.5%	59
2020 Q4	$14.6M	Hold	45,470	–	–	0.49%	64
2020 Q3	$12.2M	Buy	45,470 +3,070	+7%	+$826K	0.48%	64
2020 Q2	$11.2M	Hold	42,400	–	–	0.46%	65
2020 Q1	$9.63M	Hold	42,400	–	–	0.5%	58
2019 Q4	$12.8M	Buy	42,400 +5,240	+14%	+$1.44M	0.51%	62
2019 Q3	$8.92M	Hold	37,160	–	–	0.36%	78
2019 Q2	$10.5M	Buy	37,160 +3,360	+10%	+$918K	0.39%	71
2019 Q1	$9.7M	Buy	33,800 +13,780	+69%	+$3.99M	0.34%	78
2018 Q4	$5.26M	Hold	20,020	–	–	0.18%	104
2018 Q3	$5.49M	Buy	20,020 +1,920	+11%	+$498K	0.16%	119
2018 Q2	$4.31M	Hold	18,100	–	–	0.12%	146
2018 Q1	$3.98M	Sell	18,100 -37,263	-67%	-$8.75M	0.12%	152
2017 Q4	$12.5M	Sell	55,363 -220,580	-80%	-$47M	0.36%	79
2017 Q3	$52.4M	Sell	275,943 -30,457	-10%	-$5.8M	1.49%	13
2017 Q2	$57.6M	Sell	306,400 -63,600	-17%	-$11.4M	1.62%	12
2017 Q1	$61.2M	Buy	370,000 +81,000	+28%	+$12.9M	1.62%	12
2016 Q4	$41.5M	Buy	289,000 +91,000	+46%	+$12.2M	1.15%	21
2016 Q3	$24.8M	Buy	198,000 +113,400	+134%	+$14.6M	0.75%	42
2016 Q2	$11.1M	Sell	84,600 -1,358	-2%	-$186K	0.36%	78
2016 Q1	$11.9M	Sell	85,958 -174,000	-67%	-$23.3M	0.38%	72
2015 Q4	$36.2M	Sell	259,958 -5,162	-2%	-$711K	0.96%	32
2015 Q3	$37.1M	Sell	265,120 -14,200	-5%	-$2.13M	0.92%	32
2015 Q2	$45.8M	Buy	+279,320	New	+$44.6M	0.99%	33

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Edmond de Rothschild Holding's ELV Position: Q2 2026 in Review

Edmond de Rothschild Holding reduced its Elevance Health (ELV) stake by 82% in Q2 2026, selling an estimated $1.83M and leaving 1,094 shares worth $423K. The position accounts for 0.01% of the portfolio, ranked #385.

Edmond de Rothschild Holding first reported a position in ELV in Q2 2015 and has held it in 45 quarters since. The position peaked at $61.2M in Q1 2017. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Edmond de Rothschild Holding held 1,094 shares of Elevance Health worth $423K as of Q2 2026.
Edmond de Rothschild Holding sold 4,926 Elevance Health shares in Q2 2026, an estimated $1.83M.
Elevance Health made up 0.01% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #385 holding.
Edmond de Rothschild Holding first reported a position in Elevance Health in Q2 2015 and has held it in 45 quarters since.
Edmond de Rothschild Holding's Elevance Health position peaked at $61.2M in Q1 2017.
1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.